INVELTYS

Drug Kala Pharmaceuticals, Inc.
Total Payments
$1.3M
Transactions
32,978
Doctors
9,559
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2022 $107,546 5,046 3,002
2021 $318,772 15,758 6,583
2020 $230,639 4,671 2,225
2019 $689,667 7,503 3,379

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $784,480 32,571 58.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $427,150 166 31.7%
Consulting Fee $73,500 51 5.5%
Travel and Lodging $61,493 190 4.6%

Top Doctors Receiving Payments for INVELTYS — Page 383

Doctor Specialty Location Total Records
, O.D Optometrist Scottsdale, AZ $6.69 1
, O.D Optometrist Vancouver, WA $6.42 1
, O.D Optometrist Morrow, OH $5.94 1
, O.D Optometrist Alpharetta, GA $5.38 1
, OD Optometrist Kirkland, WA $5.11 1
, OPTOMETRIST Optometrist Christiansburg, VA $4.26 1
, O.D Optometrist Salem, VA $4.26 1
Glenn Partin Mustang, OK $3.54 1
, O.D Optometrist Tulsa, OK $2.85 1
, OD Optometrist Tulsa, OK $2.85 1

About INVELTYS

INVELTYS is a drug associated with $1.3M in payments to 9,559 healthcare providers, recorded across 32,978 transactions in the CMS Open Payments database. The primary manufacturer is Kala Pharmaceuticals, Inc..

Payment data is available from 2019 to 2022. In 2022, $107,546 was paid across 5,046 transactions to 3,002 doctors.

The most common payment nature for INVELTYS is "Food and Beverage" ($784,480, 58.3% of total).